DekaBank Deutsche Girozentrale - IMMUNOVANT INC ownership

IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 115 filers reported holding IMMUNOVANT INC in Q1 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.1%.

Quarter-by-quarter ownership
DekaBank Deutsche Girozentrale ownership history of IMMUNOVANT INC
ValueSharesWeighting
Q3 2023$1,297
+114.7%
32,6000.0%0.00%
+200.0%
Q2 2023$604
+19.8%
32,6000.0%0.00%0.0%
Q1 2023$504
-11.3%
32,6000.0%0.00%
-50.0%
Q4 2022$568
-99.7%
32,6000.0%0.00%
+100.0%
Q3 2022$177,000
+34.1%
32,6000.0%0.00%
Q2 2022$132,000
-26.3%
32,6000.0%0.00%
Q1 2022$179,000
-22.5%
32,600
+10.1%
0.00%
-100.0%
Q4 2021$231,000
-8.3%
29,600
+3.5%
0.00%0.0%
Q3 2021$252,000
-18.4%
28,6000.0%0.00%0.0%
Q2 2021$309,000
-28.0%
28,6000.0%0.00%0.0%
Q1 2021$429,000
-68.9%
28,6000.0%0.00%
-80.0%
Q4 2020$1,378,00028,6000.01%
Other shareholders
IMMUNOVANT INC shareholders Q1 2022
NameSharesValueWeighting ↓
Alpine Global Management, LLC 1,500,000$26,6258.85%
Deep Track Capital, LP 9,710,000$172,352,5007.24%
Logos Global Management LP 3,150,000$55,912,5006.55%
Ikarian Capital, LLC 966,700$17,158,9254.14%
COMMODORE CAPITAL LP 1,150,505$20,4213.08%
TCG Crossover Management, LLC 854,853$15,173,6412.68%
SILVERARC CAPITAL MANAGEMENT, LLC 519,614$9,223,1492.64%
COWEN AND COMPANY, LLC 1,250,000$22,187,5002.32%
BVF INC/IL 2,561,000$45,457,7501.92%
Eventide Asset Management 3,693,720$65,563,5301.29%
View complete list of IMMUNOVANT INC shareholders